Insights

Top brokers name 3 ASX shares to buy today

Top brokers named Pro Medicus Limited (ASX:PME) and these ASX shares as buys. Here’s why they are bullish on them…
The post Top brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia. –

finger pressing red button on keyboard labelled Buy

With many brokers still taking a well-earned break over the holiday period, broker notes are few and far between right now.

In light of this, I thought I would take a look at a few that have been released over the last few weeks that remain very relevant today.

Three buy ratings that you might want to pay attention to are listed below:

Bapcor Ltd (ASX: BAP)

According to a note out of Citi, its analysts have retained their buy rating and lifted the price target on this auto parts retailer’s shares to $8.85. The broker made the move in response to the release of a trading update from Bapcor which revealed stronger than expected sales growth in FY 2021. Citi expects this to result in a solid half year result in February. In addition to this, its analysts are fans of the company due to its defensive qualities, favourable tailwinds, and international expansion plans. The Bapcor share price is trading at $7.57 this afternoon.

Challenger Ltd (ASX: CGF)

A note out of UBS reveals that its analysts have reinstated coverage on this annuities company’s shares with a buy rating and price target of $6.85. According to the note, the broker still sees value in the Challenger share price at the current level after it recovered from a selloff at the height of the pandemic. In addition, UBS believes the risks are now to the upside in respect to Challenger’s earnings, especially given favourable regulatory developments. The Challenger share price is trading at $6.36 on Wednesday.

Pro Medicus Limited (ASX: PME)

Analysts at Morgans have retained their add rating and lifted the price target on this health imaging company’s shares to $35.02. According to the note, the broker points out that Pro Medicus has just won another major contract in the United States. The five-year contract with MedStar Health is worth a total of A$18 million. Morgans points out that this is the first time the company has signed a major cloud-only deal. It feels this could be a sign of things to come. The Pro Medicus share price is changing hands for $32.86 today.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of June 30th

More reading

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Bapcor, Challenger Limited, and Pro Medicus Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Top brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!